Overnight Health Care – Presented by Emergent Biosolutions – Pfizer, US strikes COVID-19 pill deal

Welcome to Thursday’s Overnight Health Care, where we follow the latest policy and news initiatives affecting your health. Sign up here: thehill.com/newsletter-signup.

President BidenJoe BidenHouse Democrats are pushing the vote on the plan for social spending until Friday. Fauci says all adults should ‘go and be boosted’ Senate confirms Park Service director after years of acting leaders MORE‘s first turkey pardons will be granted tomorrow to Peanut Butter and Jelly, as Sen. Mike BraunMichael BraunCruz, Braun criticizes Library of Congress for relinquishing term “illegal aliens” to suit “progressive preferences” Overnight Health Care – Presented by Emergent Biosolutions – Pfizer, US strike COVID-19 pill deal Peanut Butter and Jelly debut front the White House turkey apologized MORE (R-Ind.) Called “well-behaved.”

The United States entered into a nearly $ 5.3 million deal to buy 10 million courses of Pfizer’s COVID-19 antiviral pill.

For The Hill We Are Peter Sullivan (psullivan@thehill.com), Nathaniel Weixel (nweixel@thehill.com) and Justine Coleman (jcoleman@thehill.com). Write to us with tips and feedback, and follow us on Twitter: @ PeterSullivan4, @NateWeixel and @ JustineColeman8.

Let’s get started.

The United States buys 10 million courses of Pfizer COVID-19 pills

The Biden administration announced on Thursday that it has reached an agreement to buy 10 million courses of Pfizer’s COVID-19 treatment, in a move that officials hope will help speed up the end of the pandemic.

The $ 5.29 billion deal will allow the first deliveries of the pills to be made this year, with the order ending next year.

Pfizer’s pill, known as Paxlovid, has been shown to be very promising in trials, reducing the risk of hospitalization or death by 89 percent.

Importance: Experts say that once the pill is available, it will help end the crisis phase of the pandemic, as in addition to vaccines, it will help lower the risk of COVID-19 and make it more manageable.

“This promising treatment can help speed our way out of this pandemic by offering yet another life-saving tool for people who become ill with COVID-19,” the health and human secretary said. Xavier BecerraXavier BecerraOvernight Health Care – Presented by Emergent Biosolutions – Pfizer, US strikes COVID-19 pill deal The White House appears to be saving plan funding to ease the burden of high heating costs. The United States buys 10 million courses of Pfizer COVID-19 pills.

What’s next: The medicine still needs to be approved by the Food and Drug Administration before it can be used. Pfizer applied for approval earlier this week.

The company also announced an agreement this week to share the formula for the pill to allow low-income countries to handle it.

read more here.


Emergent has produced over 100 million Covid-19 vaccine dose equivalents. Today, these critically important doses are being sent around the world to help fight the pandemic. Get the latest news on Emergents Covid-19 answers.

The package saves around $ 160B on drug prices

Provisions to lower the prices of prescription drugs in President Bidens Build Back Better package would save the government about $ 160 billion over a decade, according to an estimate from the Congressional Budget Office released Thursday.

That includes about $ 80 billion in savings by allowing Medicare to negotiate lower drug prices in limited cases, and another about $ 80 billion in limiting drug price increases to the inflation rate.

Republicans and drug companies have attacked legislation to harm innovation and lead to fewer treatments.

The CBO estimated that the measure would result in fewer drugs entering the market in the next decade, followed by four in the next decade and five in the decade after that. It is out of about 1,300 drugs that are expected to be approved in the 30 years.

The measure included in the Democrats’ legislation, which could be passed in Parliament as soon as Thursday night, has been reduced from earlier, more sweeping proposals that Democrats have put forward to lower drug prices.

For comparison, speaker Nancy PelosiNancy PelosiHouse Democrats are pushing the vote on social spending plan until Friday. McCarthy delays a quick review of the spending plan with lengthy speech. Overnight Health Care – Presented by Emergent Biosolutions – Pfizer, US strikes COVID-19 pill deal MORE‘s 2019 measure would have saved about $ 450 billion from negotiating lower drug prices, though that measure would also have led to eight fewer drugs coming on the market over a decade, the CBO said in 2019, compared to one drug fewer in this bill.

Democrats had to step down the measure to meet the demands of a handful of moderates, including the senator. Kyrsten CinemaKyrsten SinemaOvernight Health Care – Presented by Emergent Biosolutions – Pfizer, US strike COVID-19 pill deal CBO: Democrats’ package saves around 0B on drug prices. (D-Ariz.) And Rep. Scott PetersScott H. PetersOvernight Health Care – Presented by Emergent Biosolutions – Pfizer, US strike COVID-19 pill deal CBO: Democrats’ package saves around 0B on drug prices. Democrats are positive, they reach the finish line this week (D-Calif.), Who worried that the more far-reaching version would hurt innovation.

Read more here.


AstraZeneca found that their antibody cocktail was more than 80 percent effective in preventing symptomatic COVID-19 in a business analysis published Thursday – a strong result for a treatment that could help immunocompromised people avert serious illness from COVID-19.

The drug company said their study showed that its long-acting antibody combination called AZD7442 reduced the risk of symptomatic COVID-19 by 83 percent over six months. The data has not yet been peer-reviewed, but will be sent for publication.

Researchers gave participants the single dose of 300 mg in two separate, sequential shots, most of which had sequelae that put them at high risk for severe COVID-19.

Participants were not vaccinated and the researchers will continue to study them for 15 months.

As about 2 percent of the world’s population is estimated to not have an adequate immune response to the COVID-19 vaccine, preventive treatment would be designed to help these vulnerable people prevent serious disease from the virus.

In a separate analysis of another trial, a 600 mg dose of AstraZeneca’s long-acting antibody combination was found to reduce the risk of severe COVID-19 and death by 88 percent among patients treated within three days of developing symptoms.

In work: AstraZeneca earlier submitted a request to the Food and Drug Administration (FDA) to grant an emergency use permit for AZD7442 last month.

read more here.


At Emergent, we develop, manufacture and deliver protection against threats to public health. Find out how we have improved and strengthened quality control and oversight practices in our manufacturing of bulk drug for vaccine in support of Covid-19 vaccine production.

House panel summons former Trump assistant Navarro

The House’s select subcommittee on the pandemic has issued a summons to Peter Navarro, a former senior adviser to thePresident TrumpDonald TrumpGOP Senate Candidate Says Fauci ‘Mass Murderer’ Should Be Imprisoned Rather Than ‘Completely’ Rittenhouse Overnight Health Care – Presented by Emergent Biosolutions – Pfizer, US strikes COVID-19 pill deal On The Money – House Democrats ready to build better back MORE, requesting documents and a submission in connection with the committee’s inquiry into political interference from the previous administration.

Subcommittee Chairman Rep. James Clyburn (DS.C.) claims that Navarro prioritized politics and promoted the lie that the 2020 election was stolen because of the COVID-19 reaction.

Clyburn claims that Navarro also managed millions of dollars in contracts for pandemic supplies to unprepared or politically affiliated companies, such as Eastman Kodak and Phlow.

Clyburn said Navarro, Trump’s former deputy assistant and trade adviser, has voluntarily refused to comply with repeated requests for documents since the select subcommittee first contacted him on Sept. 14.

Mr Navarro has demonstrated his unwillingness to cooperate voluntarily with the selection of the subcommittee’s examination. Given his key role in the pandemic’s response, the importance of the selection of the subcommittee’s inquiry and his continued refusal to cooperate voluntarily, this application is necessary , “Clyburn said in a note.

Looking back: According to previously released emails and documents in the committee’s investigation, Navarro sounded the alarm early on about the scale of the pandemic, urging Trump to go faster to stay ahead of the virus and secure tests, personal protective equipment and other supplies.

But he was ignored, and Trump continued to publicly downplay the seriousness of the virus. Committee Democrats claim that Navarro then pursued his own ad hoc strategy to provide important medical supplies, spend more than $ 1 billion in federal money on non-competitive contracts with little supervision.

What’s next: The lawsuit forces Navarro to provide all documents and information related to his involvement in the federal response to the coronavirus pandemic by December 8 and his appearance at a deposit on December 15.

read more here.


The leaders of Canada and Mexico on Thursday will promise to share millions of vaccine doses with other distressed countries at the first gathering of North American leaders in the White House since 2016.

Canadian Prime Minister Justin trudeauJustin Pierre James TrudeauOvernight Health Care – Presented by Emergent Biosolutions – Pfizer, US strike COVID-19 pill deal Biden says he ‘considers’ a diplomatic boycott of Beijing Olympics The Hill’s 12:30 Report – Presented by Facebook – Dems awaits excited CBO score on Build Better Back MORE and Mexican President Andrés Manuel López Obrador will meet with President Biden for the North American Leaders Summit, where the three will discuss economic initiatives, migration, climate change and the pandemic.

Leaders will announce that Canada and Mexico will send millions of vaccines to other nations in the region as part of a dose-sharing agreement after the United States first shared millions of shots with its neighbors, a senior Biden administration official told journalists on a call with preview of the summit.

The exact number of doses, recipients and timing of donations will be determined by health experts and announced at a later date, the official said, but it will be part of a broader effort to expand vaccine production capacity in the region.

“We want public health experts to determine the timing and amount and types of doses so that we work – North America – not only for our own well-being and competitiveness, but as a way to project on supporting our regional partners to recover from the pandemic stronger. than before, “said a senior administration official.

read more here.


  • Schools, paediatricians appear to be catching up on non-Covid vaccinations (Kaiser Health News)
  • The next trip of the pandemic depends on three unknowns (Atlantic Ocean)
  • Holiday COVID alarm as cases increase by 20% (Axios)



Two cheers for Democrats’ proposed drug pay reforms

That was it for today, thank you for reading along. Check out The Hill’s health care page for the latest news and coverage. See you on Friday.


Follow us on Google News

Disclaimers for mcutimes.com

All the information on this website – https://mcutimes.com – is published in good faith and for general information purposes only. mcutimes.com does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this website (mcutimes.com), is strictly at your own risk. mcutimes.com will not be liable for any losses and/or damages in connection with the use of our website.

Give a Comment